MedTrace Logo

Immersive Virtual Reality in Post Stroke

NCT04379687 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2023-09-28

No results posted yet for this study

Summary

Physiotherapy intervention programs in the post-stroke patient should develop strategies to assess functional deficit, prevent poorly adaptive plasticity and maximize functional gain. For relearning and functional training, the required activities require motor control and must comply with the following principles: movements close to normal, muscular activation, movement conduction, focused attention, repetition of desired movements, specificity of training, intensity and transfer. These principles underlie the most widely used conventional physiotherapy intervention programs in the hospital setting.

Advances in technology have made it possible to start using immersive VR in the therapeutic approach to various pathologies that affect motor function.

Conditions

  • Balance
  • Stroke
  • Physical Therapy
  • Virtual Reality

Interventions

OTHER

Virtual reality

Use of virtual reality glasses for balance work

OTHER

Control group

Balance treatment with according to Bayouk physiotherapy

Sponsors & Collaborators

  • Universidad de Zaragoza

    collaborator OTHER

  • Yolanda Marcen Roman

    lead OTHER

Principal Investigators

  • Aitor Garay Sanchez, Master · IIS Aragón

  • Mercedes Ferrando Margeli, Master · IIS Aragón

  • María Ángeles Franco Sierra, PhD · IIS Aragón

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-28
Primary Completion
2023-04-30
Completion
2023-12-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04379687 on ClinicalTrials.gov